MPLT · Company research

MapLight Therapeutics, Inc. Common Stock (MPLT): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

22records availableHealthcare

Stock News & Events data

Database-backed records only

22 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Maplight Therapeutics (NASDAQ:MPLT) Insider Sells 12,248 Shares of Stock - MarketBeatMaplight Therapeutics (NASDAQ:MPLT) Insider Sells 12,248 Shares of Stock MarketBeatView source ↗MarketBeatOct 16, 2026neutral00.6
Maplight Therapeutics (NASDAQ:MPLT) CEO Christopher Kroeger Sells 73,691 Shares of Company Stock - MarketBeatMaplight Therapeutics (NASDAQ:MPLT) CEO Christopher Kroeger Sells 73,691 Shares of Company Stock MarketBeatView source ↗MarketBeatOct 16, 2026neutral00.6
Maplight Therapeutics (NASDAQ:MPLT) CFO Sells $82,149.36 in Stock - MarketBeatMaplight Therapeutics (NASDAQ:MPLT) CFO Sells $82,149.36 in Stock MarketBeatView source ↗MarketBeatOct 16, 2026neutral00.6
Maplight Therapeutics (NASDAQ:MPLT) Insider Sells 15,355 Shares of Stock - MarketBeatMaplight Therapeutics (NASDAQ:MPLT) Insider Sells 15,355 Shares of Stock MarketBeatView source ↗MarketBeatOct 16, 2026neutral00.6
Maplight Therapeutics (NASDAQ:MPLT) Insider Sells 11,513 Shares of Company Stock - MarketBeatMaplight Therapeutics (NASDAQ:MPLT) Insider Sells 11,513 Shares of Company Stock MarketBeatView source ↗MarketBeatOct 16, 2026neutral00.6
MapLight Therapeutics, Inc. (MPLT) Stock Price, News, Quote & History - Yahoo! Finance CanadaMapLight Therapeutics, Inc. (MPLT) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 16, 2026neutral00.6
Down 29.2% in 4 Weeks, Here's Why You Should You Buy the Dip in MapLight Therapeutics, Inc. (MPLT) - Yahoo! Finance CanadaDown 29.2% in 4 Weeks, Here's Why You Should You Buy the Dip in MapLight Therapeutics, Inc. (MPLT) Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 16, 2026neutral00.6
SNDK, NVDA, SKHY, ASML Stocks Extend Slide Overnight As China’s Chip Challenge Rattles Investors - StocktwitsSNDK, NVDA, SKHY, ASML Stocks Extend Slide Overnight As China’s Chip Challenge Rattles Investors StocktwitsView source ↗StocktwitsOct 16, 2026neutral00.6
MPLT Nov 2026 40.000 call (MPLT261120C00040000) Interactive Stock Chart - Yahoo! Finance CanadaMPLT Nov 2026 40.000 call (MPLT261120C00040000) Interactive Stock Chart Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 15, 2026neutral00.6
MPLT Nov 2026 12.500 put (MPLT261120P00012500) Interactive Stock Chart - Yahoo! Finance CanadaMPLT Nov 2026 12.500 put (MPLT261120P00012500) Interactive Stock Chart Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 15, 2026neutral00.6
MPLT Nov 2026 22.500 call (MPLT261120C00022500) Interactive Stock Chart - Yahoo Finance - Yahoo! Finance CanadaMPLT Nov 2026 22.500 call (MPLT261120C00022500) Interactive Stock Chart - Yahoo Finance Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 11, 2026neutral00.6
JNJ Stock Advances After Hours On $5.5B Proposal To Resolve Talc Litigation - StocktwitsJNJ Stock Advances After Hours On $5.5B Proposal To Resolve Talc Litigation StocktwitsView source ↗StocktwitsOct 10, 2026neutral00.6
MPLT Stock Plunges 73% — Wipes Out Over $1B In Market Cap After Trial Miss On Once-Daily Dose - StocktwitsMPLT Stock Plunges 73% — Wipes Out Over $1B In Market Cap After Trial Miss On Once-Daily Dose StocktwitsView source ↗StocktwitsOct 9, 2026neutral00.6
MPLT Oct 2026 17.500 call (MPLT261016C00017500) Stock Price, News, Quote & History - Yahoo! Finance CanadaMPLT Oct 2026 17.500 call (MPLT261016C00017500) Stock Price, News, Quote & History Yahoo! Finance CanadaView source ↗Yahoo! Finance CanadaOct 9, 2026neutral00.6
MapLight co-founder is joint winner of 2026 Nobel Prize in Medicine - Seeking AlphaMapLight co-founder is joint winner of 2026 Nobel Prize in Medicine Seeking AlphaView source ↗Seeking AlphaOct 6, 2026neutral00.6
Maplight Therapeutics (NASDAQ:MPLT) Stock Falls 5.5% - Here's Why - MarketBeatMaplight Therapeutics (NASDAQ:MPLT) Stock Falls 5.5% - Here's Why MarketBeatView source ↗MarketBeatOct 5, 2026neutral00.6
Maplight Therapeutics (NASDAQ:MPLT) Stock Rating Cut to Strong Sell at Wall Street Zen - MarketBeatMaplight Therapeutics (NASDAQ:MPLT) Stock Rating Cut to Strong Sell at Wall Street Zen MarketBeatView source ↗MarketBeatOct 3, 2026neutral00.6
Insider Purchase: Director at $MPLT Buys 15,620 Shares | MPLT Stock News - Quiver QuantitativeInsider Purchase: Director at $MPLT Buys 15,620 Shares | MPLT Stock News Quiver QuantitativeView source ↗Quiver QuantitativeJul 29, 2026neutral00.6
MapLight Therapeutics stock tumbles 50% on mixed phase 2 schizophrenia data (MPLT:NASDAQ) - Seeking AlphaMapLight Therapeutics stock tumbles 50% on mixed phase 2 schizophrenia data (MPLT:NASDAQ) Seeking AlphaView source ↗Seeking AlphaJul 27, 2026neutral00.6
Is MapLight Therapeutics (MPLT) Fully Valued As Its Shares Hold Near $36.56? - Yahoo FinanceIs MapLight Therapeutics (MPLT) Fully Valued As Its Shares Hold Near $36.56? Yahoo FinanceView source ↗Yahoo FinanceJul 26, 2026neutral00.6
Is MapLight Therapeutics, Inc. (MPLT) Stock a Biotech Opportunity Ahead of the ZEPHYR Trial Readout? - Yahoo FinanceIs MapLight Therapeutics, Inc. (MPLT) Stock a Biotech Opportunity Ahead of the ZEPHYR Trial Readout? Yahoo FinanceView source ↗Yahoo FinanceJun 30, 2026neutral00.6
What a 1% Insider Sale of MPLT Stock Signals Ahead of 2026 Trial Data - The Motley FoolWhat a 1% Insider Sale of MPLT Stock Signals Ahead of 2026 Trial Data The Motley FoolView source ↗The Motley FoolApr 22, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.